Follow
John Hawboldt
John Hawboldt
Verified email at mun.ca - Homepage
Title
Cited by
Cited by
Year
Pharmacist and physician views on collaborative practice: Findings from the community pharmaceutical care project
DV Kelly, L Bishop, S Young, J Hawboldt, L Phillips, TM Keough
Canadian Pharmacists Journal/Revue des Pharmaciens du Canada 146 (4), 218-226, 2013
1982013
Management of complicated urinary tract infections in the era of antimicrobial resistance
MS Bader, J Hawboldt, A Brooks
Postgraduate medicine 122 (6), 7-15, 2010
1682010
Comparison of pharmacist managed anticoagulation with usual medical care in a family medicine clinic
S Young, L Bishop, L Twells, C Dillon, J Hawboldt, P O'Shea
BMC family practice 12, 1-7, 2011
902011
The effect of smartphone interventions on patients with chronic obstructive pulmonary disease exacerbations: a systematic review and meta-analysis
M Alwashmi, J Hawboldt, E Davis, C Marra, JM Gamble, WA Ashour
JMIR mHealth and uHealth 4 (3), e5921, 2016
852016
The iterative convergent design for mobile health usability testing: mixed methods approach
MF Alwashmi, J Hawboldt, E Davis, MD Fetters
JMIR mHealth and uHealth 7 (4), e11656, 2019
732019
Alignment of Learning Objectives and Assessments in Therapeutics Courses to Foster Higher-Order Thinking
Bev FitzPatrick, John Hawboldt, Daniel Doyle
The American Journal of Pharmaceutical Education 79 (1), 1-8, 2015
58*2015
Perceptions of health care providers regarding a mobile health intervention to manage chronic obstructive pulmonary disease: qualitative study
MF Alwashmi, B Fitzpatrick, E Davis, JM Gamble, J Farrell, J Hawboldt
JMIR mHealth and uHealth 7 (6), e13950, 2019
382019
Patients’ and physicians’ satisfaction with a pharmacist managed anticoagulation program in a family medicine clinic
L Bishop, S Young, L Twells, C Dillon, J Hawboldt
BMC research notes 8, 1-7, 2015
322015
Effectiveness of a pharmacist-driven intervention in COPD (EPIC): study protocol for a randomized controlled trial
E Davis, C Marra, JM Gamble, J Farrell, J Lockyer, JM FitzGerald, ...
Trials 17, 1-8, 2016
282016
Perceptions of patients regarding mobile health interventions for the management of chronic obstructive pulmonary disease: mixed methods study
MF Alwashmi, B Fitzpatrick, J Farrell, JM Gamble, E Davis, H Van Nguyen, ...
JMIR mHealth and uHealth 8 (7), e17409, 2020
272020
Intramuscular methotrexate-induced aseptic meningitis
J Hawboldt, M Bader
Annals of Pharmacotherapy 41 (11), 1906-1911, 2007
272007
Responses by breast and prostate cancer patients to out-of-pocket costs in Newfoundland and Labrador
E Housser, M Mathews, J LeMessurier, S Young, J Hawboldt, R West
Current Oncology 20 (3), 158-165, 2013
252013
Community-acquired pneumonia in patients with diabetes mellitus: predictors of complications and length of hospital stay
MS Bader, Y Yi, K Abouchehade, B Haroon, LD Bishop, J Hawboldt
The American journal of the medical sciences 352 (1), 30-35, 2016
212016
Features of a mobile health intervention to manage chronic obstructive pulmonary disease: a qualitative study
MF Alwashmi, B Fitzpatrick, E Davis, J Farrell, JM Gamble, J Hawboldt
Therapeutic Advances in Respiratory Disease 14, 1753466620951044, 2020
162020
Possible metoprolol-induced hyperkalemia
J Hawboldt, D McGrath
Journal of Pharmacy Practice 19 (5), 320-325, 2006
142006
Antibiotic administration longer than eight hours after triage and mortality of community-acquired pneumonia in patients with diabetes mellitus
MS Bader, KA Abouchehade, Y Yi, B Haroon, LD Bishop, J Hawboldt
European journal of clinical microbiology & infectious diseases 30, 881-886, 2011
122011
The iterative convergent design for mobile health usability testing: mixed methods approach. JMIR Mhealth Uhealth. 2019 Apr 26; 7 (4): e11656. doi: 10.2196/11656
MF Alwashmi, J Hawboldt, E Davis, MD Fetters
12
Disseminated intravascular coagulation and venous thromboembolism due to acute Epstein-Barr virus infection
MS Bader, B Haroon, J Trahey, A Al-Musawi, J Hawboldt
Infectious Diseases in Clinical Practice 19 (4), 284-285, 2011
62011
Pulmonary infection due to Mycobacterium malmoense in a patient with Crohn disease
CD Cowan, JJ Hawboldt, M Bader
The Canadian Journal of Hospital Pharmacy 62 (6), 496, 2009
62009
Risk factors of cellulitis treatment failure with once-daily intravenous cefazolin plus oral probenecid
MS Bader, L Twells, J Hawboldt
South Med J 104 (12), 789-93, 2011
52011
The system can't perform the operation now. Try again later.
Articles 1–20